Endometrial cancer in polyps: A clinical study of 27 cases

Purpose of investigation: To review risk factors, clinical presentation, diagnostic methods, and histopathologic findings in 27 cases of endometrial cancer in polyps.

Methods: A descriptive, retrospective study of 204 consecutive patients with endometrial carcinoma who were diagnosed at our institution between June 1998 to June 2001. Endometrial cancer arising in polyps occurred in 27 patients (13.2%) and accounted for 1.8% of 1492 endometrial polyps diagnosed during this period.

Results: Patients had a mean age of 62 years. All except one woman were postmenopausal. Three breast cancer patients were currently given tamoxifen. Metrorrhagia was the presenting symptom in 74% of cases, although 22% of patients were asymptomatic at the time of diagnosis. Ultrasonography performed in 22 patients showed images compatible with an endometrial polyp in 50% of cases, myoma in 5%, and inconclusive findings in 45%. The median endometrial thickness was 11 mm (range 4-33 mm). Diagnosis was made by aspiration-biopsy in 13 patients and by hysteroscopic endometrial sampling in 13 (in one patient endometrial carcinoma was incidentally found in the surgical specimen). All patients were in FIGO Stage IA. Endometrioid carcinoma was found in 81.5% of cases. Retroperitoneal metastases were not found in 25 patients undergoing pelvic lymphadenectomy, nor neoplastic growth in the specimens of six polypeptomies performed during hysteroscopy. All patients are free of relapse after a mean follow-up of 30 months.

Conclusions: Postmenopausal women with endometrial polyps diagnosed by ultrasonography should undergo directed biopsies under hysteroscopic vision. The present series confirms the good prognosis of endometrial cancer in polyps.

Endometrial cancer; Endometrial polyps; Metrorrhagia; Ultrasonography

[1] Gimpelson R.J., Rappold H.O.: "A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases". Am. J. Obstet. Gynecol., 1988, 158, 489.

[2] Towbin N.A., Gviazda l.M., March C.M.: "Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding". Am. J. Obstet. Gynecol., 1996, 174, 1678.

[3] Haller H., Matecjcic N., Rukavina B., Krasevic M., Rupcic S., Mozetic D.: "Transvaginal sonography and hysteroscopy in women with postmenopausal bleeding". Int. J. Gynaecol. Obstet., 1996, 54, 155.

[4] Loffer F.D.: "Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view". Obstet. Gynecol., 1989, 73, 16

[5] Saidi M.H., Sadler R.K., Theis V.D., Akright B.D., Farhart S.A., Villanueva G.R.: "Comparison of sonography, sonohysterography, and hysteroscopy for evaluation of abnormal uterine bleeding". J. Ultrasound Med., 1997, 16, 587.

[6] Valle R.F.: "Hysteroscopic evaluation of patients with abnormal uterine bleeding". Surg. Gynecol. Obstet., 1981, 153, 521.

[7] Syrop C.H., Sahakian V.: "Transvaginal sonographic detection of endometrial polyps with fluid contrast augmentation". Obstet Gynecol., 1992, 79, 1041.

[8] Nagele F., O'Connor H., Davies A., Badawy A., Mohamed H., Magos A.: "2500 Outpatient diagnostic hysteroscopies". Obstet Gynecol., 1996, 88, 87.

[9] Van Bogaert L.J.: "Clinicopathologic findings in endometrial polyps". Obstet. Gynecol., 1998, 71, 771.

[10] Maia H. Jr, Barbosa LC., Marques D., Calmon L.C., Ladipo O.A., Coutinho E.M.: "Hysteroscopy and transvaginal sonography in menopausal women receiving hormone replacement therapy". J. Am. Assoc. Gynecol. Laparosc., 1996, 4, 13.

[11] Ramondetta L.M., Sherwood J.B., Dunton C.J., Palazzo J.P "Endometrial cancer in polyps associated with tamoxifen use". Am. J. Obstet. Gynecol., 1999, 180, 340.

[12] Cheng W.F., Lin H.H., Tomg P.L., Huang S.C.: "Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients". Gynecol. Oneal., 1997, 66, 233.

[13] Cohen I., Rosen DJ., Shapira J., Cordoba M., Gilboa S., Altaras M.M., Yigael D., Beyth Y.: "Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer". Br. J. Obstet. Gynaecol., 1993, 100, 567.

[14] Lahti E., Blanco G., Kauppila A., Apaja-Sarkkinen M., Taskmen P.J., Laatikainen T.: "Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen". Obstet. Gynecol., 1993, 81, 660.

[15] Esteller M., Garcia A., Martfnez-Palones J.M., Xercavins J., Revent6s J.: "Endometrial carcinoma in tamoxifen-treated breast cancer patient: clinicopathological, immunohistochemical, and genetic analysis". Int. J. Gynecol. Pathol., 1999, 18, 387.

[16] Esteller M., Garcia A., Martinez J.M., Xercavins J., Revent6s J "Germ line polymorphisms in cytochrome-P450, (CA887, CY] A I), and methylenetetra-hydrofolate reductase, (MTHPR) genes and endometrial cancer susceptibly". Carcinogenesis, 1997, 18, 2307.

[17] de Wit A.C., Vleugels M.P., de Kruif J.H.: "Diagnostic hysteroscopy: a valuable diagnostic tool in the diagnosis of structural intra-cavital pathology and endometrial hyperplasia or carcinoma? Six years of experience with non-clinical diagnostic hysteroscopy". Eur. J. Obstet. Gynecol. Reprod. Biol., 2003, 110, 79.

[18] Goldstein S.R., Monteagudo A., Popiolek D., Mayberry P., TimorTritsch I.: "Evaluation of endometrial polyps". Am. J. Obstet. Gynecol., 2002, 186, 669.

[19] Vuento M.H., Pirhonen J.P., Makinen J.I., Tyrkko J.E., Laippala P.J., Gronroos M., Salmi T.A.: "Screening for endometrial cancer in asymptomatic postmenopausal women with conventional and colour Doppler sonography". Br. J. Obstet. Gynaecol., 1999, 106, 14.

[20] Perez.Medina T., Bajo J., Huertas M.A., Rubio A.: "Predicting atypia inside endometrial polyps". J. Ultrasound Med., 2002, 21, 125.

[21] Sivrides E., Fox H., Buckley C.H.: "Endometrial carcinoma: two or three entities". Int. J. Gynecol. Cancer, 1998, 8, 183.

[22] McCluggage W.G., Sumathi V.P., McManus D.T.: "Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy". Hum. Pathol., 2003, 34, 939.

[23] Bakour S.H., Khan K.S., Gupta J.K.: "The risk of premalignant and malignant pathology in endometrial polyps". Acta Obstet Gynecol. Scand., 2000, 79, 317.

[24] Anastasiadis P.G., Koutlaki N.G., Skaphida P.G., Galazios G.C., Tsikouras P .N., Liberis V.A.: "Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding". Eur. J. Gynaecol. Oneal., 2000, 21, 180.